Key result
Thrombolytic therapy for acute ischemic stroke is limited by a narrow time window due to hemorrhagic risks, prompting ongoing development of next-generation drugs to expand this window.
Why the study?
Thromboembolic ischemic stroke is a leading cause of death, prompting a review of pathophysiologic features, the history of thrombolytic therapy, and ongoing developments to safely expand the therapeutic time window.
This review summarizes the history and recent progress in the development of thrombolytic drugs for acute ischemic stroke, highlighting the need to expand the therapeutic time window.
Answers are grounded in this paper and cite their sources.
Time constraints limit thrombolysis in acute stroke; leaves open development of safer agents with extended windows.
BACKGROUND: Thromboembolic ischemic stroke, which is mainly caused by hypertension, as well as plasma dyslipidemia, arterial fibrillation and diabetes, is a leading cause of death in the US and other countries. Numerous clinical trials for thrombolytic drugs, which aimed to pharmacologically dissolve thrombi, were conducted in the 1950s, when the first thrombolytic therapy was performed. METHODS: In this study, we summarize the pathophysiologic features of ischemic stroke, and the history of thrombolytic therapy, and discuss the recent progress that has been made in the ongoing development of thrombolytic drugs. CONCLUSION: Thrombolytic therapy is sometimes accompanied by harmful hemorrhagic insults; accordingly, a window of time wherein therapy can safely be performed has been established for this approach. Several basic and clinical studies are ongoing to develop next-generation thrombolytic drugs to expand the time window.
No takes yet. Share an insight, caveat, or question.
Shibata et al. (2019) conducted a review in Acute Ischemic Stroke. Thrombolytic therapy was evaluated. Thrombolytic therapy for acute ischemic stroke is limited by a narrow time window due to hemorrhagic risks, prompting ongoing development of next-generation drugs to expand this window.
Synapse has enriched 10 related papers. Consider them for comparative context: